After experiencing it, he asked about the delivery time. Upon learning that the current production schedule was full for the next three months, he signed the order on the spot, remarking, “This is exactly the equipment I want. I am willing to wait as long as it takes—I must have it.”
In early August, a private jet took off from Riyadh, Saudi Arabia, and landed in Shanghai after a journey of over 7,000 kilometers.
Having previously been burnt by Western oxygen chamber brands, Prince Hayat—a member of the Saudi royal family—traveled to China with his family and private advisors specifically to experience the Chinese enterprise’s equipment in person.
Prince Hayat has focused on longevity technology for years. Two years ago, he spent heavily on a 1.3 ATA metal hyperbaric oxygen chamber from a European/American brand. Not only did the results fall short of expectations, but the heavy metal structure also caused slight deformation to the floor of his high-rise apartment, exposing severe safety risks.
Later, at the FIBO exhibition in Germany, Prince Hayat learned about the Chinese company Rejuvenation Lab (Rlab). His attention was immediately drawn to its new carbon-fiber oxygen chamber. After learning that its pressure could reach 1.9 ATA and its weight was 60% lighter than traditional steel chambers, he decided to make this overseas field trip.
This is far from an isolated case. Over the past two years, an increasing number of overseas high-net-worth individuals have turned their sights to this enterprise. According to staff, dozens of international clients call via the official website every month. “We manufacture a complete line of longevity equipment, including oxygen chambers, light chambers, and cryotherapy chambers. Overseas clients inquire most about cryotherapy chambers and the 1.9 ATA oxygen chambers. After testing them, many travel to the manufacturing base for on-site inspections.”
Public records show that the surge in popularity of oxygen chambers dates back to 2020. A study published in the prestigious journal Aging demonstrated that under continuous 2.0 ATA hyperbaric oxygen intervention, senescent (aging) cells in volunteers were reduced by 10% to 37%, accompanied by visible improvements such as faded age spots and increased hair growth.
This research triggered a global craze for hyperbaric oxygen anti-aging technology. Celebrities like Kim Kardashian, LeBron James, and Neymar shared their oxygen chamber experiences on social media. “Biohacker” Bryan Johnson also integrated hyperbaric oxygen therapy as a core high-frequency routine, calling it one of the most effective longevity interventions he had ever experienced, further driving adoption across Western markets.
However, Western wellness enterprises have long monopolized the core technology and pricing systems of hyperbaric chambers. Most mass-produced consumer oxygen chambers from the West reach pressure parameters of only 1.1 to 1.3 ATA. Yet, research from the Undersea and Hyperbaric Medical Society (UHMS) established long ago that oxygen chamber equipment operating below 1.5 ATA has no proven scientific efficacy for health intervention.
Chinese enterprises found a breakthrough in this technological gap. Industry reports indicate that Shanghai-based Rlab took the lead in overcoming key technical hurdles, developing the world’s first 1.9 ATA smart hyperbaric oxygen chamber. This parameter approaches the upper technological limit for consumer-grade chambers, capturing global attention.
Top international longevity clinics, such as Switzerland’s century-old CLP Life Science Center and Budapest’s IM Clinic, imported multiple core devices from Rlab after repeated inspections.
Yet this breakthrough is not merely popular abroad; since the launch of the 1.9 ATA carbon-fiber chamber, it has rapidly gained traction across tier-one Chinese cities like Beijing, Shanghai, Guangzhou, and Shenzhen. Official data shows the company has established over 50 offline experience stores across China, expanding at a rapid pace.
More notably, domestic affluent buyers have discovered expanded usage scenarios even faster than overseas users. Evolving from single-person private spaces to two-person and four-person units, oxygen chambers are transitioning from individual consumer goods into shared family and business networking spaces.
A Shanghai entrepreneur arranged a “longevity mahjong room” in his villa, placing a mahjong table inside a multi-person oxygen chamber so guests could play while receiving oxygen therapy—blending wellness with social networking. After booking an offline trial via the website and finding the results up to par, he visited Rlab’s Shanghai factory three times before placing an order. He admitted, “You have to be cautious before buying. I got burned before buying imported equipment.”
Objectively speaking, consumer hyperbaric oxygen chambers remain niche, high-end luxury products. Rlab’s models range from 450,000 RMB to nearly 900,000 RMB, remaining far from mass market adoption. The industry also faces challenges such as inconsistent technical standards and mixed product quality.
Nevertheless, when a Chinese-made oxygen chamber compels an overseas buyer to willingly wait three months, the significance extends far beyond the product itself.
Domestic hyperbaric oxygen chambers are transitioning from passively following Western standards to actively defining new industry heights. Breaking into international high-end markets is more than just one company’s success story. Market data shows China is now one of the world’s largest producers of home hyperbaric oxygen chambers, accounting for over 40% of global production capacity.
Industry analysts point out that the core of this breakthrough is technology-driven: pushing pressure parameters to consumer limits, using innovative materials to solve floor-load issues, and offering prices approximately 30% lower than Western counterparts. Combined, these factors ensure that overseas buyers traveling to China for procurement is no longer an isolated event.
As foreign media analysts noted: “Once China enters a sector, it becomes difficult for competitors to keep up.” From smartphones and new energy vehicles to oxygen chambers, intelligent Chinese manufacturing continues to shift from catching up to taking the lead. Today, in the emerging track of life sciences, the same story is playing out once again.